NCT06813105

Brief Summary

The goal of this observational study is to explore potential associations between baseline patient characteristics (such as age, body mass index, and baseline pain intensity) and clinical outcomes in patients with plantar fasciitis undergoing radial pressure wave therapy (RPWT). The study includes male and female adults aged 18 to 60 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 19, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 26, 2024

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 6, 2025

Completed
Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

1 month

First QC Date

January 24, 2025

Last Update Submit

February 3, 2025

Conditions

Keywords

plantar fasciitisrehabilitation outcomes

Outcome Measures

Primary Outcomes (1)

  • Pain intensity assessed by the Numerical Pain Rating Scale (NPRS).

    Pain intensity will be measured using the Numerical Pain Rating Scale (NPRS), a validated 10-point scale where 0 represents "no pain" and 10 represents "the worst pain imaginable."

    Immediately after the last RPWT session, approximately 1 week after baseline.

Secondary Outcomes (1)

  • Functionality assessed by the WHODAS 2.0 scale.

    Immediately after the last RPWT session, approximately 1 week after baseline.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study focuses on adult patients diagnosed with plantar fasciitis (PF), a condition commonly affecting middle-aged individuals. Eligible participants are between 18 and 60 years old and present with symptoms persisting for at least three months before treatment. Given that risk factors such as body mass index (BMI) and physical activity levels may influence clinical outcomes, these characteristics will be documented for all participants. Additionally, data on prior conventional physical therapy and PF chronicity (acute vs. chronic cases) will be collected to explore potential associations with treatment response.

You may qualify if:

  • Diagnosis of plantar fasciitis confirmed by clinical evaluation.
  • Age 18 to 60 years.
  • Symptoms persisting for at least three months before treatment.
  • Completed three RPWT sessions using a standardized protocol (2000 impulses per session, 10 Hz, and 3.5 bar).
  • Availability of complete medical records, including three-month follow-up data.

You may not qualify if:

  • History of foot surgery or corticosteroid injection in the affected limb within the past six months.
  • Pregnancy at the time of treatment.
  • Presence of concurrent musculoskeletal conditions (e.g., fractures, active infections, sprains) in the affected limb.
  • Diagnosis of systemic conditions (e.g., cancer, osteoporosis, autoimmune diseases).
  • Incomplete medical records or failure to complete RPWT sessions and follow-up visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Civil de Guadalajara Fray Antonio Alcalde

Guadalajara, Jalisco, 44280, Mexico

Location

Related Publications (4)

  • Charles R, Fang L, Zhu R, Wang J. The effectiveness of shockwave therapy on patellar tendinopathy, Achilles tendinopathy, and plantar fasciitis: a systematic review and meta-analysis. Front Immunol. 2023 Aug 16;14:1193835. doi: 10.3389/fimmu.2023.1193835. eCollection 2023.

    PMID: 37662911BACKGROUND
  • Melese H, Alamer A, Getie K, Nigussie F, Ayhualem S. Extracorporeal shock wave therapy on pain and foot functions in subjects with chronic plantar fasciitis: systematic review of randomized controlled trials. Disabil Rehabil. 2022 Sep;44(18):5007-5014. doi: 10.1080/09638288.2021.1928775. Epub 2021 May 26.

    PMID: 34038642BACKGROUND
  • Li H, Xiong Y, Zhou W, Liu Y, Liu J, Xue H, Hu L, Panayi AC, Mi B, Liu G. Shock-wave therapy improved outcome with plantar fasciitis: a meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg. 2019 Dec;139(12):1763-1770. doi: 10.1007/s00402-019-03262-z. Epub 2019 Aug 21.

    PMID: 31435724BACKGROUND
  • Vahdatpour B, Sajadieh S, Bateni V, Karami M, Sajjadieh H. Extracorporeal shock wave therapy in patients with plantar fasciitis. A randomized, placebo-controlled trial with ultrasonographic and subjective outcome assessments. J Res Med Sci. 2012 Sep;17(9):834-8.

    PMID: 23826009BACKGROUND

MeSH Terms

Conditions

Fasciitis, Plantar

Condition Hierarchy (Ancestors)

FasciitisMusculoskeletal DiseasesFoot Diseases

Study Officials

  • ARMANDO TONATIUH AVILA GARCIA, MD

    Hospital Civil de Guadalajara

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Department of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

January 24, 2025

First Posted

February 6, 2025

Study Start

November 19, 2024

Primary Completion

December 26, 2024

Study Completion

January 20, 2025

Last Updated

February 6, 2025

Record last verified: 2025-02

Locations